APR-548

DB17546InvestigationalSmall molecule

APR-548 is an analog of eprenetapopt and a reactivator of mutant p53.

Code names
APR-548

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of APR-548, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In